The Combination of Interferon-Alpha and Ponatinib Enables Faster and Deeper Molecular Responses in Patient with De Novo Blast Crisis of CML: Interferon-Alpha May Return as a CML Treatment

In the era of tyrosine kinase inhibitor (TKI) treatment, its effectiveness in treating chronic myelogenous leukemia (CML) has been improved, ensuring the same prognosis as that of healthy people of the same age. However, there are some patients with de novo blast crisis that undergoes acute conversi...

Descripción completa

Detalles Bibliográficos
Autores principales: Hayashi, Kunio, Ikegame, Kazuhiro, Takahashi, Naoto
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2021
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8112961/
https://www.ncbi.nlm.nih.gov/pubmed/34055427
http://dx.doi.org/10.1155/2021/5518727

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8112961/
https://www.ncbi.nlm.nih.gov/pubmed/34055427
http://dx.doi.org/10.1155/2021/5518727

Ejemplares similares